RxDoctor Payments Data

Rachel Pastorek

Physician Assistant · Cranberry Twp, PANPI 1679023162

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.2% of the total across 2,049 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 45 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,775in general payments, 2019–2025

Across 2,049 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$7K
  • Johnson & Johnson$6K
  • AbbVie$5K
  • Daiichi Sankyo Inc.$3K
  • UCB, Inc.$3K
  • AstraZeneca$2K
  • plus $14K from 39 others

What the payments were for

  • Speaking & faculty fees$8002%
  • Food & beverage$37,69297%
  • Education$2831%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$38,775 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
StrensiqAsfotase Alfa20$2,071,967
RinvoqUpadacitinib83$539,582
Humira(Cf) PenAdalimumab46$357,846
Cosentyx Sensoready (2 Pens)Secukinumab26$202,887
Enbrel MiniEtanercept20$143,306
Orencia ClickjectAbatacept18$100,519
EnbrelEtanercept13$95,984
ProliaDenosumab50$87,130
Actemra ActpenTocilizumab14$67,535
BenlystaBelimumab14$67,524
OtezlaApremilast12$58,547
OlumiantBaricitinib21$57,910
RasuvoMethotrexate/Pf87$51,504
TymlosAbaloparatide18$46,468
OtrexupMethotrexate/Pf35$36,649

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaStrensiq$1,992$2,071,96720 claims
AbbVieRinvoq, Savella$4,721$545,52196 claims
AmgenEnbrel, Prolia, Otezla$6,734$241,66075 claims
GSKBenlysta$1,222$67,52414 claims
Lilly USA, LLCOlumiant$1,840$57,91021 claims
Radius Health, Inc.Tymlos$455$46,46818 claims
Antares Pharma, Inc.Otrexup$16$36,64935 claims
Collegium Pharmaceutical, Inc.Xtampza Er$116$12,44418 claims
Hikma Pharmaceuticals USABuprenorphine, Mitigare$50$9,14448 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Cranberry Twp

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →